Assessment indicators of steatotic liver disease in non-hepatology specialty clinics: A real-world retrospective case-control study

doi:10.3748/wjg.121401

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 40

This Article

(6)

(5)

(0)

(4)

(72)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Oct 28, 2026; 32(40): 121401
Published online Oct 28, 2026. doi: 10.3748/wjg.121401

Table 3 After removing collinearity, one-way analysis of the association between continuous variables and steatotic liver disease

Continuous variables	SLD (n = 273)	Non-SLD (n = 244)	P value	T/U
NC, means (SE)	40.03 (3.63)	34.66 (4.27)	< 0.0001	15.445
Waist-to-hip ratio, means (SE)	0.98 (0.06)	0.89 (0.07)	< 0.0001	15.013
TyG-WHtR¹, median (IQR)	5.57 (5.09-6.01)	4.34 (3.79-4.95)	< 0.0001	8275.000
HSI, means (SE)	44.11 (7.08)	33.94 (7.66)	< 0.0001	15.497
CVAI¹, median (IQR)	145.31 (107.11-191.65)	63.45 (33.44-98.05)	< 0.0001	8993.000
Thigh circumference¹, median (IQR)	59.70 (56.03-63.50)	52.28 (48.10-56.98)	< 0.0001	12359.500
ALM%, means (SE)	463.93 (56.28)	405.13 (56.20)	< 0.0001	11.866

¹Because it does not conform to the normal distribution, the Mann-Whitney test is used.

TyG-WHtR: Triglyceride glucose-waist-to-height ratio; SLD: Steatotic liver disease; IQR: Interquartile range; HSI: Hepatic steatosis index; CVAI: Chinese Visceral Adiposity Index; ALM%: The sum of the muscle mass percentages of right upper limb, right lower limb, left upper limb, and left lower limb, muscle mass percentage = muscle mass/ideal muscle mass × 100; NC: Neck circumference.

Full Size Table

Citation: Li ZK, Cai JT, Zhang PH, Wang LL, Yan HH. Assessment indicators of steatotic liver disease in non-hepatology specialty clinics: A real-world retrospective case-control study. World J Gastroenterol 2026; 32(40): 121401
URL: https://www.wjgnet.com/1007-9327/full/v32/i40/121401.htm
DOI: https://dx.doi.org/10.3748/wjg.121401

Li ZK, Cai JT, Zhang PH, Wang LL, Yan HH. Assessment indicators of steatotic liver disease in non-hepatology specialty clinics: A real-world retrospective case-control study. World J Gastroenterol 2026; 32(40): 121401 [DOI: 10.3748/wjg.121401]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.